Cadherin cell adhesion system in canine mammary cancer: A review

Veterinary Medicine International

Volumn 2012, Issue , 2012, Pages

  Gama, Adelina ^a   Schmitt, Fernando ^b,c  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866150168     PISSN: None     EISSN: 20420048     Source Type: Journal    
DOI: 10.1155/2012/357187     Document Type: Review

References (96)

1. Misdorp W., Meuten D. J., Tumours of the mammary gland. Tumors in Domestic Animals 2002 4th Ames, Iowa, USA Iowa State Press, Blackwell 575 606
2. Gilbertson S. R., Kurzman I. D., Zachrau R. E., Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 1983 20 2 127 142 2-s2.0-0020571917 (Pubitemid 13087502)
3. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J. F., Niemi S., Comstock K. E., Ostrander E., Westmoreland S., Withrow S., The dog as a cancer model. Nature Biotechnology 2006 24 9 1065 1066 2-s2.0-33748516371 10.1038/nbt0906-1065b (Pubitemid 44359705)
4. Olson P. N., Using the canine genome to cure cancer and other diseases. Theriogenology 2007 68 3 378 381 2-s2.0-34347357467 10.1016/j.theriogenology. 2007.04.016 (Pubitemid 47017432)
5. Makrilia N., Kollias A., Manolopoulos L., Syrigos K., Cell adhesion molecules: role and clinical significance in cancer. Cancer Investigation 2009 27 10 1023 1037 2-s2.0-70450218151 10.3109/07357900902769749
6. Takeichi M., Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991 251 5000 1451 1455 2-s2.0-0025894092 (Pubitemid 121000430)
7. Gumbiner B. M., Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996 84 3 345 357 2-s2.0-0030056968 10.1016/S0092-8674(00)81279-9 (Pubitemid 26058560)
8. Li D. M., Feng Y. M., Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets. Breast Cancer Research and Treatment 2011 128 1 7 21 2-s2.0-79959255482 10.1007/s10549-011-1499-x
9. Nose A., Takeichi M., A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. Journal of Cell Biology 1986 103 6 2649 2658 2-s2.0-0022895355 (Pubitemid 17008011)
10. Knudsen K. A., Wheelock M. J., Cadherins and the mammary gland. Journal of Cellular Biochemistry 2005 95 3 488 496 2-s2.0-23944501378 10.1002/jcb.20419 (Pubitemid 41420179)
11. Knudsen K. A., Frankowski C., Johnson K. R., Wheelock M. J., A role for cadherins in cellular signaling and differentiation. Journal of Cellular Biochemistry. Supplement 1998 30-31 168 176 2-s2.0-0032254262 (Pubitemid 29028738)
12. 2+-dependent cell-cell adhesion molecule homologous to mouse placental cadherin: its low expression in human placental tissues. Journal of Cell Biology 1989 109 4 I 1787 1794 2-s2.0-0024466702 (Pubitemid 19251224)
13. Hatta K., Takeichi M., Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 1986 320 6061 447 449 2-s2.0-0022621979 (Pubitemid 16097807)
14. Nose A., Nagafuchi A., Takeichi M., Isolation of placental cadherin cDNA: identification of a novel gene family of cell-cell adhesion molecules. The EMBO Journal 1987 6 12 3655 3661 2-s2.0-0023461753
15. Miyatani S., Shimamura K., Hatta M., Nagafuchi A., Nose A., Matsunaga M., Hatta K., Takeichi M., Neural cadherin: role in selective cell-cell adhesion. Science 1989 245 4918 631 635 2-s2.0-0024403904 (Pubitemid 19213339)
16. Paredes J., Correia A. L., Ribeiro A. S., Albergaria A., Milanezi F., Schmitt F. C., P-cadherin expression in breast cancer: a review. Breast Cancer Research 2007 9 5 214 2-s2.0-40449115153
17. Ozawa M., Barbault H., Kemler R., The cytoplasmic domain of the cell adhesion molecule uvomorulin assoicates with three independent proteins structurally related in different species. The EMBO Journal 1989 8 6 1711 1717 2-s2.0-0024451982 (Pubitemid 19273986)
18. Vleminckx K., Vakaet L. Jr., Mareel M., Fiers W., Van Roy F., Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991 66 1 107 119 2-s2.0-0025818032 (Pubitemid 121001351)
19. McCrea P. D., Turck C. W., Gumbiner B., A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 1991 254 5036 1359 1361 2-s2.0-0026316099 (Pubitemid 21917467)
20. Peifer M., McCrea P. D., Green K. J., Wieschaus E., Gumbiner B. M., The vertebrate adhesive junction proteins β -catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. Journal of Cell Biology 1992 118 3 681 691 2-s2.0-0026661360 10.1083/jcb.118.3.681
21. Behrens J., Von Kries J. P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W., Functional interaction of β -catenin with the transcription factor LEF-1. Nature 1996 382 6592 638 642 2-s2.0-0029781509 10.1038/382638a0 (Pubitemid 26268958)
22. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B. G., Kemler R., Nuclear localization of β -catenin by interaction with transcription factor LEF-1. Mechanisms of Development 1996 59 1 3 10 2-s2.0-0345343608 10.1016/0925-4773(96)00597-7 (Pubitemid 26325455)
23. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destrée O., Clevers H., XTcf-3 transcription factor mediates β -catenin-induced axis formation in xenopus embryos. Cell 1996 86 3 391 399 2-s2.0-0001003110 10.1016/S0092-8674(00)80112-9 (Pubitemid 26272079)
24. van de Wetering M., Cavallo R., Dooijes D., Van Beest M., Van Es J., Loureiro J., Ypma A., Hursh D., Jones T., Bejsovec A., Peifer M., Mortin M., Clevers H., Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997 88 6 789 799 2-s2.0-0030999806 10.1016/S0092-8674(00)81925-X (Pubitemid 27164267)
25. Berx G., Van Roy F., The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Research 2001 3 5 289 293 2-s2.0-0034852853 10.1186/bcr309 (Pubitemid 32851157)
26. Brown A. M. C., Wnt signaling in breast cancer: have we come full circle? Breast Cancer Research 2001 3 6 351 355 2-s2.0-0035719960 10.1186/bcr321 (Pubitemid 34196359)
27. Gavert N., Ben-Ze'ev A., β -catenin signaling in biological control and cancer. Journal of Cellular Biochemistry 2007 102 4 820 828 2-s2.0-35648949978 10.1002/jcb.21505 (Pubitemid 350036922)
28. Rowlands T. M., Pechenkina I. V., Hatsell S. J., Pestell R. G., Cowin P., Dissecting the roles of β -catenin and cyclin D1 during mammary development and neoplasia. Proceedings of the National Academy of Sciences of the United States of America 2003 100 20 11400 11405 2-s2.0-0141816802 10.1073/pnas.1534601100 (Pubitemid 37205947)
29. Yap A. S., Niessen C. M., Gumbiner B. M., The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p 120 ctn. Journal of Cell Biology 1998 141 3 779 789 2-s2.0-0032482201 10.1083/jcb.141.3.779 (Pubitemid 28217921)
30. Ohkubo T., Ozawa M., p 120 ctn binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity. The Journal of Biological Chemistry 1999 274 30 21409 21415 2-s2.0-0033597896 10.1074/jbc.274.30.21409 (Pubitemid 29350616)
31. Anastasiadis P. Z., Moon S. Y., Thoreson M. A., Mariner D. J., Crawford H. C., Zheng Y., Reynolds A. B., Inhibition of RhoA by p120 catenin. Nature Cell Biology 2000 2 9 637 644 2-s2.0-0001468710 10.1038/35023588
32. Wheelock M. J., Soler A. P., Knudsen K. A., Cadherin junctions in mammary tumors. Journal of Mammary Gland Biology and Neoplasia 2001 6 3 275 285 2-s2.0-0035406784 10.1023/A:1011319507155 (Pubitemid 39600487)
33. Restucci B., Papparella S., De Vico G., Maiolino P., E cadherin expression in normal and neoplastic canine mammary gland. Journal of Comparative Pathology 1997 116 2 191 202 2-s2.0-0030894415 10.1016/S0021-9975(97)80076-X (Pubitemid 27139891)
34. Sarli G., Preziosi R., De Tolla L., Brunetti B., Benazzi C., E-cadherin immunoreactivity in canine mammary tumors. Journal of Veterinary Diagnostic Investigation 2004 16 6 542 547 2-s2.0-8844230394 10.1177/104063870401600608 (Pubitemid 39527181)
35. Gama A., Paredes J., Gärtner F., Alves A., Schmitt F., Expression of E-cadherin, P-cadherin and β -catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Veterinary Journal 2008 177 1 45 53 2-s2.0-44449140414 10.1016/j.tvjl.2007.05. 024 (Pubitemid 351753675)
36. Palacios J., Benito N., Pizarro A., Suarez A., Espada J., Cano A., Gamallo C., Anomalous expression of P-cadherin in breast carcinoma: correlation with E-cadherin expression and pathological features. American Journal of Pathology 1995 146 3 605 612 2-s2.0-0028955864
37. Gama A., Paredes J., Milanezi M. F., Reis-Filho J. S., Gartner F., Schmitt F. C., P-cadherin expression in canine lactating mammary gland. Journal of Cellular Biochemistry 2002 86 3 420 421 2-s2.0-0036944351 10.1002/jcb.10245 (Pubitemid 36076159)
38. Gama A., Paredes J., Albergaria A., Gartner F., Schmitt F., P-cadherin expression in canine mammary tissues. Journal of Comparative Pathology 2004 130 1 13 20 2-s2.0-0442326191 10.1016/S0021-9975(03)00064-1 (Pubitemid 38185948)
39. Soler A. P., Russo J., Russo I. H., Knudsen E K. A., Soluble fragment of P-cadherin adhesion protein found in human milk. Journal of Cellular Biochemistry 2002 85 1 180 184 2-s2.0-0036192550 10.1002/jcb.10126 (Pubitemid 34204080)
40. Reis A. L., Carvalheira J., Schmitt F. C., Gärtner F., Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Veterinary Record 2003 152 20 621 624 2-s2.0-0038446585 (Pubitemid 36656796)
41. Brunetti B., Sarli G., Preziosi R., Monari I., Benazzi C., E-cadherin and β -catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Veterinary Pathology 2005 42 6 781 787 2-s2.0-28144452566 10.1354/vp.42-6-781 (Pubitemid 41695361)
42. Matos A. J. F., Lopes C., Carvalheira J., Santos M., Rutteman G. R., Gärtner F., E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. Journal of Comparative Pathology 2006 134 2-3 182 189 2-s2.0-33645891195 10.1016/j.jcpa.2005.10.004
43. de Matos A. J. F., Lopes C. C. C., Faustino A. M. R., Carvalheira J. G. V., Rutteman G. R., Gärtner M. D. F. R. M., E-cadherin, β -catenin, invasion and lymph node metastases in canine malignant mammary tumours. Acta Pathologica, Microbiologica et Immunologica 2007 115 4 327 334 2-s2.0-34248593582 10.1111/j.1600-0463.2007.apm544.x (Pubitemid 46745228)
44. Nowak M., Madej J. A., Dziegiel P., Expression of E-cadherin, β -catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches. Folia Histochemica et Cytobiologica 2007 45 3 233 238 2-s2.0-35548979450 (Pubitemid 350018140)
45. Rodo A., Malicka E., E-cadherin immimohistochemical expression in mammary gland neoplasms in bitches. Polish Journal of Veterinary Sciences 2008 11 1 47 54 2-s2.0-41349114859 (Pubitemid 351449422)
46. Wijnhoven B. P. L., Dinjens W. N. M., Pignatelli M., E-cadherin-catenin cell-cell adhesion complex and human cancer. British Journal of Surgery 2000 87 8 992 1005 2-s2.0-0033930954 10.1046/j.1365-2168.2000.01513.x (Pubitemid 30496847)
47. Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W., E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. Journal of Cell Biology 1991 113 1 173 185 2-s2.0-0025765115 (Pubitemid 21909684)
48. Peri A. K., Wilgenbus P., Dahl U., Semb H., Christofori G., A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998 392 6672 190 193 2-s2.0-0032510494 10.1038/32433 (Pubitemid 28162793)
49. Vos C. B. J., Cleton-Jansen A. M., Berx G., De Leeuw W. J. F., Ter Haar N. T., Van Roy F., Cornelisse C. J., Peterse J. L., Van De Vijver M. J., E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumerigenesis. British Journal of Cancer 1997 76 9 1131 1133 2-s2.0-0030817611 (Pubitemid 27448007)
50. Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., Cano A., Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. American Journal of Pathology 1993 142 4 987 993 2-s2.0-0027772231 (Pubitemid 24060574)
51. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., Takatsuka Y., Matsuyoshi N., Hirano S., Takeichi M., Mori T., Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Research 1993 53 7 1696 1701 2-s2.0-0027530351 (Pubitemid 23113254)
52. Siitonen S. M., Kononen J. T., Helin H. J., Rantala I. S., Holli K. A., Isola J. J., Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. American Journal of Clinical Pathology 1996 105 4 394 402 2-s2.0-0029926185 (Pubitemid 26105132)
53. Bukholm I. K., Nesland J. M., Karesen R., Jacobsen U., Borresen-Dale A. L., E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. Journal of Pathology 1998 185 262 266 (Pubitemid 28320047)
54. Heimann R., Lan F., McBride R., Hellman S., Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Research 2000 60 2 298 304 2-s2.0-0034650772 (Pubitemid 30070755)
55. Madhavan M., Srinivas P., Abraham E., Ahmed I., Mathew A., Vijayalekshmi N. R., Balaram P., Cadherins as predictive markers of nodal metastasis in breast cancer. Modern Pathology 2001 14 5 423 427 2-s2.0-0035038940 10.1038/modpathol.3880329 (Pubitemid 32448740)
56. Yoshida R., Kimura N., Harada Y., Ohuchi N., The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. International Journal of Oncology 2001 18 3 513 520 2-s2.0-0035286576
57. Berx G., Cleton-Jansen A. M., Nollet F., De Leeuw W. J. F., Van De Vijver M. J., Cornelisse C., Van Roy F., E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. The EMBO Journal 1995 14 24 6107 6115 2-s2.0-0029558476 (Pubitemid 26007298)
58. Ressel L., Millanta F., Poli A., Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases. Journal of Comparative Pathology 2011 144 4 303 307 2-s2.0-79953703685 10.1016/j.jcpa.2010.08.015
59. Nowak M., Madej J. A., Podhorska-Okolow M., Dziegiel P., Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas. In Vivo 2008 22 4 463 470 2-s2.0-48349132141
60. Kovács A., Dhillon J., Walker R. A., Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Journal of Clinical Pathology 2003 56 6 318 322 2-s2.0-0347504931 10.1136/mp.56.6.318 (Pubitemid 37521923)
61. Gillett C. E., Miles D. W., Ryder K., Skilton D., Liebman R. D., Springall R. J., Barnes D. M., Hanby A. M., Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. Journal of Pathology 2001 193 4 433 441 2-s2.0-0035068950 10.1002/path.831 (Pubitemid 32266811)
62. Howard E. M., Lau S. K., Lyles R. H., Birdsong G. G., Umbreit J. N., Kochhar R., Expression of E-cadherin in high-risk breast cancer. Journal of Cancer Research and Clinical Oncology 2005 131 1 14 18 2-s2.0-11244354303 10.1007/s00432-004-0618-z
63. Spieker N., Mareel M., Bruyneel E. A., Nederbragt H., E-cadherin expression and in vitro invasion of canine mammary tumor cells. European Journal of Cell Biology 1995 68 4 427 436 2-s2.0-0029585542 (Pubitemid 26004233)
64. Brunetti B., Sarli G., Preziosi R., Leprotti S., Benazzi C., E-cadherin expression in canine mammary carcinomas with regional lymph node metastases. Journal of Veterinary Medicine A 2003 50 10 496 500 2-s2.0-3042767906 10.1111/j.1439-0442.2003.00577.x (Pubitemid 41742988)
65. Bukholm I. K., Nesland J. M., Re-expression of E-cadherin, α -catenin and β -catenin, but not of γ -catenin, in metastatic tissue from breast cancer patients.,Journal of Pathology 2000 190 15 19 (Pubitemid 30053348)
66. Pinho S. S., Osório H., Nita-Lazar M., Gomes J., Lopes C., Gärtner F., Reis C. A., Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochemical and Biophysical Research Communications 2009 379 4 1091 1096 2-s2.0-58949097354 10.1016/j.bbrc.2009.01.024
67. Gonzalez M. A., Pinder S. E., Wencyk P. M., An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. Journal of Pathology 1999 187 523 529 (Pubitemid 29151992)
68. Soler A., Knudsen K. A., Salazar H., Han A. C., Keshgegian A. A., P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999 86 1263 1272 (Pubitemid 29447011)
69. Dolled-Filhart M., McCabe A., Giltnane J., Cregger M., Camp R. L., Rimm D. L., Quantitative in situ analysis of β -catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Research 2006 66 10 5487 5494 2-s2.0-33744938180 10.1158/0008-5472.CAN-06-0100 (Pubitemid 43844977)
70. Gould Rothberg B. E., Bracken M. B., E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis. Breast Cancer Research and Treatment 2006 100 2 139 148 2-s2.0-33750367989 10.1007/s10549-006-9248-2 (Pubitemid 44631915)
71. Park D., Kåresen R., Axcrona U., Noren T., Sauer T., Expression pattern of adhesion molecules (E-cadherin, α -, β -, γ -catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Acta Pathologica, Microbiologica et Immunologica 2007 115 1 52 65 2-s2.0-33846092040 10.1111/j.1600-0463.2007.apm524.x (Pubitemid 46066574)
72. Kleer C. G., van Golen K. L., Braun T., Merajver S. D., Persistent E-cadherin expression in inflammatory breast cancer. Modern Pathology 2001 14 5 458 464 2-s2.0-0035031712 10.1038/modpathol.3880334 (Pubitemid 32448745)
73. Charafe-Jauffret E., Tarpin C., Bardou V. J., Bertucci F., Ginestier C., Braud A. C., Puig B., Geneix J., Hassoun J., Bimbaum D., Jacquemier J., Viens P., Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature' Journal of Pathology 2004 202 3 265 273 2-s2.0-12144287780 10.1002/path.1515 (Pubitemid 38325235)
74. Gamallo C., Moreno-Bueno G., Sarrió D., Calero F., Hardisson D., Palacios J., The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Modern Pathology 2001 14 7 650 654 2-s2.0-0034920218 10.1038/modpathol.3880367 (Pubitemid 32667208)
75. Paredes J., Milanezi F., Reis-Filho J. S., Leitão D., Athanazio D., Schmitt F., Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathology Research and Practice 2002 198 12 795 801 2-s2.0-0036997114 10.1078/0344-0338-00338 (Pubitemid 36221701)
76. Arnes J. B., Brunet J. S., Stefansson I., Bégin L. R., Wong N., Chappuis P. O., Akslen L. A., Foulkes W. D., Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clinical Cancer Research 2005 11 11 4003 4011 2-s2.0-20344377896 10.1158/1078-0432.CCR-04-2064 (Pubitemid 40791563)
77. Paredes J., Albergaria A., Oliveira J. T., Jeronimo C., Milanezi F., Schmitt F. C., P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clinical Cancer Research 2005 11 16 5869 5877 2-s2.0-23844489449 10.1158/1078-0432.CCR-05-0059 (Pubitemid 41170315)
78. Turashvili G., McKinney S. E., Goktepe O., Leung S. C., Huntsman D. G., Gelmon K. A., Los G., Rejto P. A., Aparicio S. A. J. R., P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer. Modern Pathology 2011 24 1 64 81 2-s2.0-78650921170 10.1038/modpathol. 2010.189
79. Han A. C., Soler A. P., Knudsen K. A., Salazar H., Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Human Pathology 1999 30 9 1035 1039 2-s2.0-0032887757 10.1016/S0046-8177(99)90220-4 (Pubitemid 29427159)
80. Reis-Filho J. S., Milanezi F., Paredes J., Silva P., Pereira E. M., Maeda S. A., De Carvalho L. V., Schmitt F. C., Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Applied Immunohistochemistry and Molecular Morphology 2003 11 1 1 8 2-s2.0-0037347755 10.1097/00022744-200303000-00001 (Pubitemid 36372997)
81. Perou C. M., Sorile T., Eisen M. B., Van De Rijn M., Jeffrey S. S., Ress C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge O., Pergammenschlkov A., Williams C., Zhu S. X., Lonning P. E., Borresen-Dale A. L., Brown P. O., Botstein D., Molecular portraits of human breast tumours. Nature 2000 406 6797 747 752 2-s2.0-0034680102 10.1038/35021093
82. Sorlie T., Perou C. M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M. B., Van De Rijn M., Jeffrey S. S., Thorsen T., Quist H., Matese J. C., Brown P. O., Botstein D., Lonning P. E., Borresen-Dale A. L., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 2001 98 19 10869 10874 2-s2.0-0035845511 10.1073/pnas.191367098 (Pubitemid 32878711)
83. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J. S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C. M., Lonning P. E., Brown P. O., Borresen-Dale A. L., Botstein D., Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8418 8423 2-s2.0-0037478605 10.1073/pnas.0932692100 (Pubitemid 36842560)
84. Sotiriou C., Neo S. Y., McShane L. M., Korn E. L., Long P. M., Jazaeri A., Martiat P., Fox S. B., Harris A. L., Liu E. T., Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10393 10398 2-s2.0-0042838307 10.1073/pnas.1732912100 (Pubitemid 37071889)
85. Prat A., Parker J. S., Karginova O., Fan C., Livasy C., Herschkowitz J. I., He X., Perou C. M., Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research 2010 12 5, article R68 2-s2.0-78049308800 10.1186/bcr2635
86. Nielsen T. O., Hsu F. D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., Akslen L. A., Ragaz J., Gown A. M., Gilks C. B., Van De Rijn M., Perou C. M., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clinical Cancer Research 2004 10 16 5367 5374 2-s2.0-4143150688 10.1158/1078-0432.CCR-04-0220 (Pubitemid 39100473)
87. Matos I., Dufloth R., Alvarenga M., Zeferino L. C., Schmitt F., p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Archiv 2005 447 4 688 694 2-s2.0-27644567107 10.1007/s00428-005-0010-7 (Pubitemid 41571183)
88. Rakha E. A., El-Sayed M. E., Reis-Filho J., Ellis I. O., Patho-biological aspects of basal-like breast cancer. Breast Cancer Research and Treatment 2009 113 3 411 422 2-s2.0-58549119990 10.1007/s10549-008-9952-1
89. Sousa B., Paredes J., Milanezi F., Lopes N., Martins D., Dufloth R., Vieira D., Albergaria A., Veronese L., Carneiro V., Carvalho S., Costa J. L., Zeferino L., Schmitt F., P-cadherin, Vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histology and Histopathology 2010 25 8 963 974 2-s2.0-77956895496
90. Gama A., Alves A., Schmitt F., Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Archiv 2008 453 2 123 132 2-s2.0-49349088861 10.1007/s00428-008-0644-3
91. Paredes J. C., Milanezi M. F. G., Reis-Filho J. S., Leitão D. R. A., Athanazio D. A., De Landér Schmitt F. C., Correlation between P-cadherin and estrogen receptor expression in breast cancer. Jornal Brasileiro de Patologia e Medicina Laboratorial 2002 38 4 307 313 2-s2.0-52649094917
92. Paredes J., Stove C., Stove V., Milanezi F., Van Marck V., Derycke L., Mareel M., Bracke M., Schmitt F., P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Research 2004 64 22 8309 8317 2-s2.0-8544229187 10.1158/0008-5472.CAN-04-0795 (Pubitemid 39491769)
93. Albergaria A., Ribeiro A. S., Pinho S., Milanezi F., Carneiro V., Sousa B., Sousa S., Oliveira C., Machado J. C., Seruca R., Paredes J., Schmitt F., ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBP β in CDH3 gene activation. Human Molecular Genetics 2010 19 13 2554 2566 2-s2.0-77954172745 10.1093/hmg/ddq134
94. Ribeiro A. S., Albergaria A., Sousa B., Correia A. L., Bracke M., Seruca R., Schmitt F. C., Paredes J., Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 2010 29 3 392 402 2-s2.0-75149183984 10.1038/onc.2009.338
95. Taniuchi K., Nakagawa H., Hosokawa M., Nakamura T., Eguchi H., Ohigashi H., Ishikawa O., Katagiri T., Nakamura Y., Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating Rho-family GTPases. Cancer Research 2005 65 8 3092 3099 2-s2.0-17144371898 (Pubitemid 40524589)
96. Zhang C. C., Yan Z., Zhang Q., Kuszpit K., Zasadny K., Qiu M., Painter C. L., Wong A., Kraynov E., Arango M. E., Mehta P. P., Popoff I., Casperson G. F., Los G., Bender S., Anderes K., Christensen J. G., VanArsdale T., PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clinical Cancer Research 2010 16 21 5177 5188 2-s2.0-78049460090 10.1158/1078-0432.CCR-10-1343